title: Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
abstract: This study performed on 6 conscious cats with chronic pancreatic fistulas was designed to determine the role of cholecystokinin (CCK), gastrin and gastrin-releasing peptide (GRP) in stimulation of pancreatic secretion in this species. Pancreatic response to GRP infused intravenously in graded doses appears to be mediated predominantly by CCK because a CCK receptor antagonist, L-364,718, abolished this response. Also, gastrin appears to mediate in part the secretory response to GRP because blockade of gastrin receptors by L-365,260, given at the dose that completely abolished the pancreatic response to exogenous gastrin, caused a significant reduction in the bombesin-induced pancreatic secretion. CCK and partly gastrin appear to mediate the postprandial pancreatic secretion in cats as the administration of L-364,718 and L-365,260 inhibited this secretion by over 90 and 30%, respectively. In contrast, GRP does not seem to contribute to food-induced pancreatic secretory stimulation, because the blockade of GRP receptors using novel bombesin/GRP antagonist (RC-3100) failed to affect this secretion. We conclude that CCK and partly gastrin, but not GRP, play an essential role in the postprandial pancreatic secretion.
authors.affiliation: Institute of Physiology, Academy of Medicine, Krakow, Poland.
authors.forename: S J
authors.initials: SJ
authors.lastname: Konturek
authors.forename: J
authors.initials: J
authors.lastname: Bilski
authors.forename: M
authors.initials: M
authors.lastname: Hladij
authors.forename: E
authors.initials: E
authors.lastname: Krzyzek
authors.forename: R Z
authors.initials: RZ
authors.lastname: Cai
authors.forename: A V
authors.initials: AV
authors.lastname: Schally
mesh_terms: D000681:Amylases / Q000378:metabolism; D000818:Animals; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000494:pharmacology; D002415:Cats; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D020109:Devazepide; D004305:Dose-Response Relationship, Drug; D004435:Eating; D019886:Gastrin-Releasing Peptide; D005755:Gastrins / Q000494:pharmacology / Q000502:physiology*; D010179:Pancreas / Q000201:enzymology / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology / Q000502:physiology*; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors
chemical_list: D001570:Benzodiazepinones; D005755:Gastrins; D010455:Peptides; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C058121:L 365260; D019886:Gastrin-Releasing Peptide; D002766:Cholecystokinin; D000681:Amylases; D020109:Devazepide